ArticleCancer science2018

Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition.

Myung Jin Ban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.